Publications by authors named "Encarna Montesinos Villaescusa"
Successful outcome of psoriasis in a laryngeal cancer patient treated with ixekizumab, a possible beneficial treatment for both pathologies.
Saray Porcar Saura Lucía Martínez Casimiro Alejandro García Vázquez Martí Pons Benavent Santiago Guillén-Climent Encarna Montesinos Villaescusa
Dermatol Online J
June 2021
A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients.
José-María Ortiz-Salvador Martina Saneleuterio-Temporal Jorge Magdaleno-Tapial Manel Velasco-Pastor Conrad Pujol-Marco Encarna Montesinos-Villaescusa
J Am Acad Dermatol
August 2019
Background: Secukinumab is a first-in-class interleukin 17A monoclonal antibody that has demonstrated an excellent safety and efficacy profile in phase 3 studies.
Objective: To evaluate the effectiveness of secukinumab in daily clinical practice and to understand the clinical and epidemiologic characteristics of patients treated with secukinumab in clinical settings.
Methods: In this multicenter prospective observational study, we recruited adult patients with moderate-to-severe plaque psoriasis from 12 hospitals in Spain during January-December 2016.